FDA.reportPublic FDA data

Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection

RxCUI
2698778
RxNorm name
Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection
Display name
Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection
Full name
Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125722KEBILIDIeladocagene exuparvovec-tneq351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KEBILIDIELADOCAGENE EXUPARVOVEC-TNEQPTC Therapeutics, Inc.9d6a6401-c6b5-4f29-af11-67707d2494822026-06-11Warnings, Adverse reactionsExact identifier
rxcui: 2698778

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9d6a6401-c6b5-4f29-af11-67707d249482Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection [PSN] · 0.5 ML eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection [Kebilidi] [SBD] · 0.5 ML Kebilidi 560000000000 VECTOR-GENOMES/ML Injection [SY] · Kebilidi 560,000,000,000 VECTOR-GENOMES per 0.5 ML Injection [SY]43These highlights do not include all the information needed to use KEBILIDI safely and effectively. See full prescribing information for KEBILIDI. KEBILIDI (eladocagene exuparvovec-tneq) suspension, for intraputaminal infusion Initial U.S. Approval: 202420260113